Anti- Dxd (Exatecan derivative for ADC) antibody, mAbYKZP1802

Anti- Dxd (Exatecan derivative for ADC) antibody, mAb YKZP1802

抗Dxd 鼠單抗

編號：YKZP1802

Background
Dxd (Exatecan derivative for ADC) is a potent DNA topoisomerase I inhibitor, with an IC50 of 0.31 μM, used as a conjugated drug of HER2-targeting ADC (DS-8201a). Dxd is cytotoxic to human cancer cell lines of KPL-4, NCI-N87, SK-BR-3, and MDA-MB-468 with IC50s of 1.43 nM-4.07 nM, but the control IgG-ADC (Dxd is the payload) shows no inhibition on the four cell lines (with HER2 expression). DS-8201a (Dxd is the payload) displays significant suppression on the HER2-positive KPL-4, NCI-N87, and SK-BR-3 cell lines, with IC50 values of 26.8, 25.4, and 6.7 ng/mL, respectively, but with no such inhibition on MDA-MB-468 (IC50, >10,000 ng/mL).

Anti- Dxd (Exatecan derivative for ADC) antibody, mAb YKZP1802

Monomethyl auristatin E (MMAE; SGD-1010) 是海兔毒素10的合成衍生物，通過抑制微管蛋白聚合而起到有效的有絲分裂抑制作用。MMAE廣泛用作細胞毒性成分制作抗體-藥物偶聯物 (ADCs) 以治療癌癥。

Dxd (Exatecan derivative for ADC) is a potent inhibitor of DNA topoisomerase I (IC50: 0.31 μM). It is used as a conjugated drug of HER2-targeting ADC.

#ADC-Ab0001 mouse monoclonal antibody can recognize Dxd and Dxd structurally similar molecules

Concentration:

1 mg/ml. Protein was determined by OD280 absorbance.

Physical State:Liquid

Reactivity:

Dxd and Dxd structurally similar molecules

Storage Condition:Store at -20 °C. Stable for 12 months from date of receipt.

Anti-MMAF (Monomethyl Auristain F) antibody, mAb YKZP1802

抗MMAF鼠單抗 

Background

Monomethyl auristatin F (MMAF) is a synthetic antineoplastic agent. It is part of the approved drug belantamab mafodotin in multiple myeloma and some experimental anti-cancer antibody-drug conjugates such as vorsetuzumab mafodotin and SGN-CD19A. In International Nonproprietary Names for MMAF-antibody-conjugates, the name mafodotin refers to MMAF plus its attachment structure to the antibody.

 Anti-MMAF (Monomethyl Auristain F) antibody, mAb

MMAF (Monomethylauristatin F) hydrochloride 是一種有效的微管蛋白聚合 (tubulin polymerization) 抑制劑，用作抗腫瘤藥物。MMAF hydrochloride 廣泛用作抗體偶聯藥物 (ADCs) 的細胞毒性成分，如 Vorsetuzumab mafodotin 和 SGN-CD19A。